GENE ONLINE|News &
Opinion
Blog

2026-06-04|

ATP Binding to Amyloid Fibrils Reduces Cellular Toxicity by Altering Protein Structure

by GOAI
Share To

Researchers identified a mechanism in a 2026 study published in *Cell Death Discovery* where adenosine triphosphate (ATP) binds to amyloid fibrils and alters their structural composition, resulting in a decrease in cellular toxicity. The study examined how ATP interacts with fibrils formed by lysozyme and superfolder green fluorescent protein (sfGFP) to modify their physical state.

The investigation demonstrates that ATP acts as a biological agent capable of remodeling these protein aggregates. By binding to the amyloid fibrils, ATP changes their structural configuration, which subsequently mitigates the harmful effects typically associated with these protein structures in biological systems. These findings provide new data regarding the functional roles of ATP beyond its traditional use as an energy source, specifically highlighting its influence on protein aggregation and cellular health.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
2026-06-18
PNC Multifamily Capital Launches $251.4 Million Affordable Housing Investment Fund
2026-06-18
ArcelorMittal, thyssenkrupp, and voestalpine Call for EU Emissions Trading System Reforms to Protect Steel Competitiveness
2026-06-18
Hillman Group and Hillwood Begin Construction on Dallas-Fort Worth Multipurpose Facility
2026-06-18
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
2026-06-18
2026 Tang Prize in Biopharmaceutical Science Honors Three Pioneers of “Living Drug” Immunotherapies
2026-06-17
How One South Korean Hospital Built a Global Reputation Around a $5 Billion Surgical Standard
2026-06-16
Scroll to Top